Immune Complex Membranoproliferative Glomerulonephritis
📧 Sign up to get email alerts when something new happens for Immune Complex Membranoproliferative Glomerulonephritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: An Open-Label, Nonrandomized, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan in Participants With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis [Phase 3]
An open-label, nonrandomized multicenter extension study to assess the long-term safety and efficacy of Pegcetacoplan in participants with C…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of iptacopan in participants with immune complex membranoproliferative glomerulo…
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis [Phase 3]
Phase 3 trial evaluating pegcetacoplan for C3 glomerulopathy and immune-complex membranoproliferative glomerulonephritis has completed with …
-
CLINICAL_TRIALS trial_result · 2022-08-11Clinical Trial Update: A Proof of Concept Study for a 12 Month Treatment in Patients With C3G or IC-MPGN Treated With ACH-0144471 [Phase 2]
Phase 2 proof-of-concept trial for a 12-month treatment in C3 glomerulopathy-related conditions (C3 Glomerulonephritis/IC-MPGN) with ACH-014…